<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/vsp.v22i5.2623</article-id><article-id custom-type="elpub" pub-id-type="custom">vsp-3307</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Опыт применения адалимумаба при лечении суппуративного гидраденита, сочетающегося с синдромом Рэппа – Ходжкина</article-title><trans-title-group xml:lang="en"><trans-title>Adalimumab Experience in the Management of Hidradenitis Suppurativa Burdened with Rapp-Hodgkin Syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2252-8570</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мурашкин</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Murashkin</surname><given-names>Nikolay N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мурашкин Николай Николаевич - доктор медицинских наук, профессор, руководитель НИИ детской дерматологии, заведующий отделением дерматологии и аллергологии, заведующий лабораторией патологии кожи у детей отдела научных исследований в педиатрии ФГАУ «НМИЦ здоровья детей» Минздрава России, профессор кафедры дерматовенерологии и косметологии ФГБУ ДПО «ЦГМУ» УДП РФ, профессор кафедры педиатрии и детской ревматологии ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет).</p><p>119991, Москва, Ломоносовский пр-т, д. 2, стр. 1, тел.: +7 (495) 967-14-20</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">m_nn2001@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6034-8231</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Материкин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Materikin</surname><given-names>Alexander I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4107-4642</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Епишев</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Epishev</surname><given-names>Roman V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5739-0941</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леонова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Leonova</surname><given-names>Maria A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0858-8780</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Опрятин</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Opryatin</surname><given-names>Leonid A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9777-0156</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федоров</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorov</surname><given-names>Dmitri V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0081-0981</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>Roman A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6884-5171</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савелова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savelova</surname><given-names>Alena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4773-2842</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Катунина</surname><given-names>О. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Katunina</surname><given-names>Oksana R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1107-8693</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>Kirill A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3044-184X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Уфимцева</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Ufimtseva</surname><given-names>Anastasiya U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НМИЦ здоровья детей; Первый МГМУ им. И.М. Сеченова (Сеченовский Университет); ЦГМА</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health; Sechenov First Moscow State Medical University; Central State Medical Academy of Department of Presidential Affairs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НМИЦ здоровья детей</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children’s Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>РМАНПО</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2023</year></pub-date><volume>22</volume><issue>5</issue><fpage>450</fpage><lpage>457</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мурашкин Н.Н., Материкин А.И., Епишев Р.В., Леонова М.А., Опрятин Л.А., Федоров Д.В., Иванов Р.А., Савелова А.А., Катунина О.Р., Куликов К.А., Уфимцева А.Ю., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Мурашкин Н.Н., Материкин А.И., Епишев Р.В., Леонова М.А., Опрятин Л.А., Федоров Д.В., Иванов Р.А., Савелова А.А., Катунина О.Р., Куликов К.А., Уфимцева А.Ю.</copyright-holder><copyright-holder xml:lang="en">Murashkin N.N., Materikin A.I., Epishev R.V., Leonova M.A., Opryatin L.A., Fedorov D.V., Ivanov R.A., Savelova A.A., Katunina O.R., Kulikov K.A., Ufimtseva A.U.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/3307">https://vsp.spr-journal.ru/jour/article/view/3307</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Синдром Рэппа – Ходжкина — редкое генетическое заболевание, относящееся к группе эктодермальных дисплазий, проявлениями которого являются поражение структур, происходящих из эктодермы — слоя эмбриональной ткани, которая обеспечивает формирование многих органов и тканей организма, включая кожу, потовые железы, волосы, зубы и ногти. Симптомы заболевания могут варьировать от легкой до тяжелой степени и включать в себя аномалии зубов, ломкие, редкие или отсутствующие волосы, аномальные ногти, гипогидроз (ввиду уменьшенного количества потовых желез), расщелины губы и неба. Суппуративный гидраденит — хроническое воспалительное заболевание, которое преимущественно поражает участки расположения апокринных желез. Данная нозология характеризуется образованием болезненных узлов, абсцессов и свищей, склонных к рецидивированию и приводящих к рубцеванию.</p><p>Описание клинического случая. Авторами представлен клинический случай, демонстрирующий сочетание синдрома Рэппа – Ходжкина с тяжелым суппуративным гидраденитом у пациента мужского пола 17 лет.</p></sec><sec><title>Заключение</title><p>Заключение. Гетерогенная клиническая картина суппуративного гидраденита, а также «фон» в виде редкого генетического заболевания заставляет пациентов обращаться к медицинским специалистам различного профиля, что приводит к несвоевременной верификации диагноза и, как следствие, некорректным методам лечения. В результате чего к моменту постановки диагноза пациенты имеют стойкие эстетические дефекты кожи, возможные осложнения нерационального лечения, а также снижение качества жизни.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Rapp-Hodgkin syndrome is a rare genetic disease from the ectodermal dysplasia group. It manifests with damage of ectodermal structures — layer of embrional tissue that provides the development of many organs and tissues in the body, such as: skin, sweat glands, hair, teeth, and nails. Disease symptoms may range from mild to severe and include dental abnormalities, fragile, thin or no hair, abnormal nails, hypohidrosis (due to the reduced number of sweat glands), cleft lips and palate. Hidradenitis suppurativa is a chronic inflammatory disease that predominantly affects apocrine glands areas. This nosology is characterized by painful nodes, abscesses, and fistulas, prone to relapses and leading to scarring.</p><p>Clinical case description. The authors present a clinical case demonstrating the combination of Rapp-Hodgkin syndrome and severe hidradenitis suppurativa in 17-year-old male patient.</p></sec><sec><title>Conclusion</title><p>Conclusion. The heterogeneous clinical findings of hidradenitis suppurativa and history of rare genetic disease result in patients' admissions to various medical specialists. Thus, it leads to delayed verification of the diagnosis and incorrect treatment methods. As a result, patients have persistent cosmetic skin defects, possible complications of irrational treatment, and decreased quality of life by the time of diagnosis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром Рэппа – Ходжкина</kwd><kwd>эктодермальная дисплазия</kwd><kwd>суппуративный гидраденит</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Rapp-Hodgkin syndrome</kwd><kwd>ectodermal dysplasia</kwd><kwd>hidradenitis suppurativa</kwd><kwd>clinical case</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Отсутствует</funding-statement><funding-statement xml:lang="en">Not specified</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Morrell DS, Burkhart CN, Siegel D. Chapter 26 — Selected Hereditary Diseases. In: Neonatal Dermatology. Eichenfield LF, Frieden IJ, Esterly NB, eds. 2nd ed. W.B. Saunders; 2008. pp. 477–501. doi: https://doi.org/10.1016/B978-1-4160-3432-2.50029-7</mixed-citation><mixed-citation xml:lang="en">Morrell DS, Burkhart CN, Siegel D. Chapter 26 — Selected Hereditary Diseases. In: Neonatal Dermatology. Eichenfield LF, Frieden IJ, Esterly NB, eds. 2nd ed. W.B. Saunders; 2008. pp. 477–501. doi: https://doi.org/10.1016/B978-1-4160-3432-2.50029-7</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chatterjee M, Neema S, Mukherjee S. Rapp Hodgkin Syndrome. Indian Dermatol Online J. 2017;8(3):215–216. doi: https://doi.org/10.4103/idoj.IDOJ_100_16</mixed-citation><mixed-citation xml:lang="en">Chatterjee M, Neema S, Mukherjee S. Rapp Hodgkin Syndrome. Indian Dermatol Online J. 2017;8(3):215–216. doi: https://doi.org/10.4103/idoj.IDOJ_100_16</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Brueggemann FB, Bartsch O. A recurrent TP63 mutation causing EEC3 and Rapp-Hodgkin syndromes. Clin Dysmorphol. 2016;25(2):50–53. doi: https://doi.org/10.1097/MCD.0000000000000117</mixed-citation><mixed-citation xml:lang="en">Brueggemann FB, Bartsch O. A recurrent TP63 mutation causing EEC3 and Rapp-Hodgkin syndromes. Clin Dysmorphol. 2016;25(2):50–53. doi: https://doi.org/10.1097/MCD.0000000000000117</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt J, Schreiber G, Altmüller J, et al. Familial cleft tongue caused by a unique translation initiation codon variant in TP63. Eur J Hum Genet. 2022;30(2):211–218. doi: https://doi.org/10.1038/s41431-021-00967-x</mixed-citation><mixed-citation xml:lang="en">Schmidt J, Schreiber G, Altmüller J, et al. Familial cleft tongue caused by a unique translation initiation codon variant in TP63. Eur J Hum Genet. 2022;30(2):211–218. doi: https://doi.org/10.1038/s41431-021-00967-x</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khandelwal KD, van den Boogaard MH, Mehrem SL, et al. Deletions and loss-of-function variants in TP63 associated with orofacial clefting. Eur J Hum Genet. 2019;27(7):1101–1112. doi: https://doi.org/10.1038/s41431-019-0370-0</mixed-citation><mixed-citation xml:lang="en">Khandelwal KD, van den Boogaard MH, Mehrem SL, et al. Deletions and loss-of-function variants in TP63 associated with orofacial clefting. Eur J Hum Genet. 2019;27(7):1101–1112. doi: https://doi.org/10.1038/s41431-019-0370-0</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Majmundar VD, Baxi K. Ectodermal Dysplasia. 2022 Jul 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation><mixed-citation xml:lang="en">Majmundar VD, Baxi K. Ectodermal Dysplasia. 2022 Jul 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wawrzycki B, Pietrzak A, Chodorowska G, et al. Ectrodactylyectodermal dysplasia-clefting syndrome with unusual cutaneous vitiligoid and psoriasiform lesions due to a novel single point TP63 gene mutation. Postepy Dermatol Alergol. 2019;36(3):358–364. doi: https://doi.org/10.5114/ada.2018.73437</mixed-citation><mixed-citation xml:lang="en">Wawrzycki B, Pietrzak A, Chodorowska G, et al. Ectrodactylyectodermal dysplasia-clefting syndrome with unusual cutaneous vitiligoid and psoriasiform lesions due to a novel single point TP63 gene mutation. Postepy Dermatol Alergol. 2019;36(3):358–364. doi: https://doi.org/10.5114/ada.2018.73437</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Akter S, Hossain S, Ali MA, et al. Comprehensive Characterization of the Coding and Non-Coding Single Nucleotide Polymorphisms in the Tumor Protein p63 (TP63) Gene Using In Silico Tools. Biomolecules. 2021;11(11):1733. doi: https://doi.org/10.3390/biom11111733</mixed-citation><mixed-citation xml:lang="en">Akter S, Hossain S, Ali MA, et al. Comprehensive Characterization of the Coding and Non-Coding Single Nucleotide Polymorphisms in the Tumor Protein p63 (TP63) Gene Using In Silico Tools. Biomolecules. 2021;11(11):1733. doi: https://doi.org/10.3390/biom11111733</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nanda A, AlLafi A, Wolf S, et al. TP63-related disorders: two case reports and a brief review of the literature. Dermatol Online J. 2021;27(11). doi: https://doi.org/10.5070/D3271156088</mixed-citation><mixed-citation xml:lang="en">Nanda A, AlLafi A, Wolf S, et al. TP63-related disorders: two case reports and a brief review of the literature. Dermatol Online J. 2021;27(11). doi: https://doi.org/10.5070/D3271156088</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kirby B, Caird A, Rogers S. Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia. Br J Dermatol. 1999;141(1): 175. doi: https://doi.org/10.1046/j.1365-2133.1999.02954.x</mixed-citation><mixed-citation xml:lang="en">Kirby B, Caird A, Rogers S. Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia. Br J Dermatol. 1999;141(1): 175. doi: https://doi.org/10.1046/j.1365-2133.1999.02954.x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zabel J, Dańczak D. Case of ectodermal dysplasia with maintained function of sweat glands and extensive acne. Przegl Dermatol. 1977;64(6):725–728.</mixed-citation><mixed-citation xml:lang="en">Zabel J, Dańczak D. Case of ectodermal dysplasia with maintained function of sweat glands and extensive acne. Przegl Dermatol. 1977;64(6):725–728.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Musumeci ML, Fiorentini F, Bianchi L, et al. Follicular occlusion tetrad in a male patient with pachyonychia congenita: clinical and genetic analysis. J Eur Acad Dermatol Venereol. 2019;33 Suppl 6:36–39. doi: https://doi.org/10.1111/jdv.15851</mixed-citation><mixed-citation xml:lang="en">Musumeci ML, Fiorentini F, Bianchi L, et al. Follicular occlusion tetrad in a male patient with pachyonychia congenita: clinical and genetic analysis. J Eur Acad Dermatol Venereol. 2019;33 Suppl 6:36–39. doi: https://doi.org/10.1111/jdv.15851</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chen W, Plewig G. Should hidradenitis suppurativa/acne inversa best be renamed as “dissecting terminal hair folliculitis”? Exp Dermatol. 2017;26(6):544–547. doi: https://doi.org/10.1111/exd.13211357</mixed-citation><mixed-citation xml:lang="en">Chen W, Plewig G. Should hidradenitis suppurativa/acne inversa best be renamed as “dissecting terminal hair folliculitis”? Exp Dermatol. 2017;26(6):544–547. doi: https://doi.org/10.1111/exd.13211357</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82(5):1045–1058. doi: https://doi.org/10.1016/j.jaad.2019.08.090</mixed-citation><mixed-citation xml:lang="en">Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82(5):1045–1058. doi: https://doi.org/10.1016/j.jaad.2019.08.090</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ingram JR. Hidradenitis suppurativa: an update. Clin Med. 2016; 16(1):70–73. doi: https://doi.org/10.7861/clinmedicine.16-1-70</mixed-citation><mixed-citation xml:lang="en">Ingram JR. Hidradenitis suppurativa: an update. Clin Med. 2016; 16(1):70–73. doi: https://doi.org/10.7861/clinmedicine.16-1-70</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Onderdijk AJ, van der Zee HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473–478. doi: https://doi.org/10.1111/j.1468-3083.2012.04468.x</mixed-citation><mixed-citation xml:lang="en">Onderdijk AJ, van der Zee HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27(4):473–478. doi: https://doi.org/10.1111/j.1468-3083.2012.04468.x</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Delany E, Gormley G, Hughes R, et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018;32(3): 467–473. doi: https://doi.org/10.1111/jdv.14686</mixed-citation><mixed-citation xml:lang="en">Delany E, Gormley G, Hughes R, et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018;32(3): 467–473. doi: https://doi.org/10.1111/jdv.14686</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546–1549. doi: https://doi.org/10.1111/bjd.14038</mixed-citation><mixed-citation xml:lang="en">Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546–1549. doi: https://doi.org/10.1111/bjd.14038</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Aroonsakul N, Phinyo P, Lumkul L, et al. Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies. BMJ Open. 2022;12(9):e062351. doi: https://doi.org/10.1136/bmjopen-2022-062351</mixed-citation><mixed-citation xml:lang="en">Aroonsakul N, Phinyo P, Lumkul L, et al. Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies. BMJ Open. 2022;12(9):e062351. doi: https://doi.org/10.1136/bmjopen-2022-062351</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol. 2015;73(5 Suppl 1): S36–S41. doi: https://doi.org/10.1016/j.jaad.2015.07.051</mixed-citation><mixed-citation xml:lang="en">Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol. 2015;73(5 Suppl 1): S36–S41. doi: https://doi.org/10.1016/j.jaad.2015.07.051</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tiri H, Jokelainen J, Timonen M, et al. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2018;79(3):514–519. doi: https://doi.org/10.1016/j.jaad.2018.02.067</mixed-citation><mixed-citation xml:lang="en">Tiri H, Jokelainen J, Timonen M, et al. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2018;79(3):514–519. doi: https://doi.org/10.1016/j.jaad.2018.02.067</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sachdeva M, Kim P, Mufti A, et al. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review. J Cutan Med Surg. 2022;26(2):176–180. doi: https://doi.org/10.1177/12034754211049711</mixed-citation><mixed-citation xml:lang="en">Sachdeva M, Kim P, Mufti A, et al. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review. J Cutan Med Surg. 2022;26(2):176–180. doi: https://doi.org/10.1177/12034754211049711</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai YC, Hung CY, Tsai TF. Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis. Pharmaceutics. 2023;15(5):1351. doi: https://doi.org/10.3390/pharmaceutics15051351</mixed-citation><mixed-citation xml:lang="en">Tsai YC, Hung CY, Tsai TF. Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis. Pharmaceutics. 2023;15(5):1351. doi: https://doi.org/10.3390/pharmaceutics15051351</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Koguchi-Yoshioka H, Wataya-Kaneda M, Yutani M, et al. Atopic diathesis in hypohidrotic/anhidrotic ectodermal dysplasia. Acta Derm Venereol. 2015;95(4):476–479. doi: https://doi.org/10.2340/00015555-1978</mixed-citation><mixed-citation xml:lang="en">Koguchi-Yoshioka H, Wataya-Kaneda M, Yutani M, et al. Atopic diathesis in hypohidrotic/anhidrotic ectodermal dysplasia. Acta Derm Venereol. 2015;95(4):476–479. doi: https://doi.org/10.2340/00015555-1978</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Vossen ARJV, Ardon CB, van der Zee HH, et al. The antiinflammatory potency of biologics targeting tumour necrosis factor, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Br J Dermatol. 2019;181(2):314–323. doi: https://doi.org/10.1111/bjd.17641</mixed-citation><mixed-citation xml:lang="en">Vossen ARJV, Ardon CB, van der Zee HH, et al. The antiinflammatory potency of biologics targeting tumour necrosis factor, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Br J Dermatol. 2019;181(2):314–323. doi: https://doi.org/10.1111/bjd.17641</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Scheinfeld N. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013;19(4):1.</mixed-citation><mixed-citation xml:lang="en">Scheinfeld N. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013;19(4):1.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Saunte DML, Jemec GBE. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. JAMA. 2017;318(20):2019–2032. doi: https://doi.org/10.1001/jama.2017.16691</mixed-citation><mixed-citation xml:lang="en">Saunte DML, Jemec GBE. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. JAMA. 2017;318(20):2019–2032. doi: https://doi.org/10.1001/jama.2017.16691</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Хобейш М.М., Шустов Д.В., Соколовский Е.В. Гидраденит суппуративный: современные представления о патогенезе, терапии и успешный опыт лечения адалимумабом // Вестник дерматологии и венерологии. — 2017. — № 5. — С. 70–81. — doi: https://doi.org/10.25208/0042-4609-2017-93-5-70-81</mixed-citation><mixed-citation xml:lang="en">Khobeish MM, Shustov DV, Sokolovsky EV. Hidradenitis Suppurativa: Modern Concepts of Pathogenesis and Therapy; Successful Experience of Adalimumab Therapy. Vestnik Dermatologii i Venerologii. 2017;(5):70–81. (In Russ). doi: https://doi.org/10.25208/ 0042-4609-2017-93-5-70-81</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Bahillo Monné C, Honorato Guerra S, Schoendorff Ortega C, Gargallo Quintero AB. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature. Dermatology. 2014;229(4):279–287. doi: https://doi.org/10.1159/000365076</mixed-citation><mixed-citation xml:lang="en">Bahillo Monné C, Honorato Guerra S, Schoendorff Ortega C, Gargallo Quintero AB. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature. Dermatology. 2014;229(4):279–287. doi: https://doi.org/10.1159/000365076</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
